Toll-like receptors in the respiratory system: Their roles in inflammation
Tóm tắt
Từ khóa
Tài liệu tham khảo
Chaudhuri N, Dower SK, Whyte MK, et al.: Toll-like receptors and chronic lung disease. Clin Sci (Lond) 2005, 109:125–133.
Trinchieri G, Sher A: Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 2007, 7:179–190.
Marks GB: Environmental factors and gene-environment interactions in the aetiology of asthma. Clin Exp Pharmacol Physiol 2006, 33:285–289.
Schroder NW, Maurer M: The role of innate immunity in asthma: leads and lessons from mouse models. Allergy 2007, 62:579–590.
Eder W, Klimecki W, Yu L, et al.: Toll-like receptor 2 as a major gene for asthma in children of European farmers. J Allergy Clin Immunol 2004, 113:482–488.
Cockcroft DW, Davis BE: Mechanisms of airway hyperresponsiveness. J Allergy Clin Immunol 2006, 118:551–559; quiz 560–551.
Voynow JA, Gendler SJ, Rose MC: Regulation of mucin genes in chronic inflammatory airway diseases. Am J Respir Cell Mol Biol 2006, 34:661–665.
Monick MM, Powers LS, Hassan I, et al.: Respiratory syncytial virus synergizes with Th2 cytokines to induce optimal levels of TARC/CCL17. J Immunol 2007, 179:1648–1658.
Elsner J, Escher SE, Forssmann U: Chemokine receptor antagonists: a novel therapeutic approach in allergic diseases. Allergy 2004, 59:1243–1258.
Hiscott J: Triggering the innate antiviral response through IRF-3 activation. J Biol Chem 2007, 282:15325–15329.
Solis M, Goubau D, Romieu-Mourez R, et al.: Distinct functions of IRF-3 and IRF-7 in IFN-α gene regulation and control of anti-tumor activity in primary macrophages. Biochem Pharmacol 2006, 72:1469–1476.
Sen GC, Sarkar SN: Transcriptional signaling by double-stranded RNA: role of TLR3. Cytokine Growth Factor Rev 2005, 16:1–14.
Iwasaki A, Medzhitov R: Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004, 5:987–995.
Schnare M, Barton GM, Holt AC, et al.: Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001, 2:947–950.
Hollingsworth JW, Whitehead GS, Lin KL, et al.: TLR4 signaling attenuates ongoing allergic inflammation. J Immunol 2006, 176:5856–5862.
Kanzler H, Barrat FJ, Hessel EM, et al.: Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med 2007, 13:552–559.
Revets H, Pynaert G, Grooten J, et al.: Lipoprotein I, a TLR2/4 ligand modulates Th2-driven allergic immune responses. J Immunol 2005, 174:1097–1103.
Sel S, Wegmann M, Sel S, et al.: Immunomodulatory effects of viral TLR ligands on experimental asthma depend on the additive effects of IL-12 and IL-10. J Immunol 2007, 178:7805–7813.
Redecke V, Hacker H, Datta SK, et al.: Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 2004, 172:2739–2743.
Eisenbarth SC, Piggott DA, Huleatt JW, et al.: Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 2002, 196:1645–1651.
Kim YK, Oh SY, Jeon SG, et al.: Airway exposure levels of lipopolysaccharide determine type 1 versus type 2 experimental asthma. J Immunol 2007, 178:5375–5382.
Bauer S, Hangel D, Yu P: Immunobiology of toll-like receptors in allergic disease. Immunobiology 2007, 212:521–533.
Duez C, Gosset P, Tonnel AB: Dendritic cells and toll-like receptors in allergy and asthma. Eur J Dermatol 2006, 16:12–16.
Harrington LE, Hatton RD, Mangan PR, et al.: Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 6:1123–1132.
Infante-Duarte C, Horton HF, Byrne MC, et al.: Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol 2000, 165:6107–6115.
Park H, Li Z, Yang XO, et al.: A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 6:1133–1141.
Bettelli E, Carrier Y, Gao W, et al.: Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235–238.
Mangan PR, Harrington LE, O’Quinn DB, et al.: Transforming growth factor-beta induces development of the Th17 lineage. Nature 2006, 441:231–234.
Ivanov, II, McKenzie BS, Zhou L, et al.: The orphan nuclear receptor ROR γt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006, 126:1121–1133.
Veldhoen M, Hocking RJ, Atkins CJ, et al.: TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179–189.
Weaver CT, Harrington LE, Mangan PR, et al.: Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity 2006, 24:677–688.
Bullens DM, Truyen E, Coteur L, et al.: IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res 2006, 7:135.
Schnyder-Candrian S, Togbe D, Couillin I, et al.: Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med 2006, 203:2715–2725.
Galli SJ, Nakae S, Tsai M: Mast cells in the development of adaptive immune responses. Nat Immunol 2005, 6:135–142.
Kulka M, Alexopoulou L, Flavell RA, et al.: Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol 2004, 114:174–182.
Nigo YI, Yamashita M, Hirahara K, et al.: Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function. Proc Natl Acad Sci U S A 2006, 103:2286–2291.
Qiao H, Andrade MV, Lisboa FA, et al.: FcɛR1 and toll-like receptors mediate synergistic signals to markedly augment production of inflammatory cytokines in murine mast cells. Blood 2006, 107:610–618.
Matsushima H, Yamada N, Matsue H, et al.: TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J Immunol 2004, 173:531–541.
Homma T, Kato A, Hashimoto N, et al.: Corticosteroid and cytokines synergistically enhance toll-like receptor 2 expression in respiratory epithelial cells. Am J Respir Cell Mol Biol 2004, 31:463–469.
Sha Q, Truong-Tran AQ, Plitt JR, et al.: Activation of airway epithelial cells by toll-like receptor agonists. Am J Respir Cell Mol Biol 2004, 31:358–364.
Proud D, Chow CW: Role of viral infections in asthma and chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2006, 35:513–518.
Matsukura S, Kokubu F, Kurokawa M, et al.: Synthetic double-stranded RNA induces multiple genes related to inflammation through Toll-like receptor 3 depending on NF-B and/or IRF-3 in airway epithelial cells. Clin Exp Allergy 2006, 36:1049–1062.
Liu YJ: Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 2006, 203:269–273.
Ziegler SF, Liu YJ: Thymic stromal lymphopoietin in normal and pathogenic T cell development and function. Nat Immunol 2006, 7:709–714.
Kato A, Favoreto S Jr, Avila PC, et al.: TLR3-and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J Immunol 2007, 179:1080–1087.
Wong CK, Cheung PF, Ip WK, et al.: Intracellular signaling mechanisms regulating toll-like receptor-mediated activation of eosinophils. Am J Respir Cell Mol Biol 2007, 37:85–96.
Didierlaurent A, Ferrero I, Otten LA, et al.: Flagellin promotes myeloid differentiation factor 88-dependent development of Th2-type response. J Immunol 2004, 172:6922–6930.
Hessel EM, Chu M, Lizcano JO, et al.: Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction. J Exp Med 2005, 202:1563–1573.
Tulic MK, Fiset PO, Christodoulopoulos P, et al.: Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response. J Allergy Clin Immunol 2004, 113:235–241.
Simons FE, Shikishima Y, Van Nest G, et al.: Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA. J Allergy Clin Immunol 2004, 113:1144–1151.